Mar 4
INMB · Inmune Bio, Inc. · Documents
$0.89
-0.01 (-0.70%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$27.68M
Shares
30.96M
Volume · Nov 20
19.48K
Avg daily vol (3M)
342.92K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2021
Mar 2
Current report
8-K
Events of Feb 25
Other events
Jan 25
Current report
8-K
Events of Jan 19
Director or officer change, or executive pay
Jan 21
Current report
8-K
Other events
Jan 21
Current report
8-K
Other events
Jan 19
Current report
8-K
Events of Jan 12
Other events
Jan 4
Current report
8-K/A
Events of Dec 30
Entered into a material agreement, Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change
2020
Dec 30
Current report
8-K
Events of Dec 29
Other events
Dec 30
Nov 12
Current report
8-K
Events of Nov 11
Other events
Nov 9
Current report
8-K
Events of Nov 5
Other events
Nov 6
Earnings call
Q3 2020 earnings call
Nov 6
Current report
8-K
Events of Nov 5
Financial results
Nov 5
Oct 27
Current report
8-K
Other events
Oct 6
Current report
8-K
Events of Oct 5
Other events
Oct 1
Current report
8-K
Events of Sep 30
Shareholder vote results
Sep 29
Current report
8-K
Other events
Sep 24
Current report
8-K
Events of Sep 23
Other events
Sep 17
Current report
8-K
Events of Sep 14
Other events
Sep 15
Current report
8-K
Events of Sep 14
Other events
Sep 4
Current report
8-K
Events of Sep 3
Other events
Sep 3
Current report
8-K
Events of Sep 1
Other events
Aug 21
Proxy statement
DEF 14A
Meeting Sep 30, 2020
Proxy statement
Aug 19
Current report
8-K
Events of Aug 18
Entered into a material agreement
Aug 14
Current report
8-K
Events of Aug 13
Other events
Aug 7
Current report
8-K
Events of Aug 5
Other events
Aug 6
Earnings call
Q2 2020 earnings call
Aug 6
Current report
8-K
Events of Aug 5
Financial results
Aug 5
Aug 3
Current report
8-K
Events of Jul 31
Other events
Jul 30
Current report
8-K
Other events
Jul 28
Current report
8-K
Events of Jul 27
Other events
Jul 21
Current report
8-K/A
Events of Jul 17
Other events
Jul 20
Current report
8-K
Events of Jul 17
Other events
Jul 16
Current report
8-K
Entered into a material agreement, Other events
Jul 13
Current report
8-K
Other events
Jul 10
Current report
8-K
Events of Jul 9
Other events
Jun 15
Current report
8-K
Events of Jun 11
Other events
May 20
Current report
8-K
Events of May 19
Other events
May 18
Current report
8-K
Other events
May 15
Earnings call
Q1 2020 earnings call
May 15
Current report
8-K
Events of May 14
Financial results
May 14
May 12
Current report
8-K
Events of May 11
Other events
May 7
Current report
8-K
Events of May 6
Other events
May 5
Current report
8-K
Other events
Apr 28
Current report
8-K
Other events
Apr 23
Current report
8-K
Other events
Apr 22
Current report
8-K
Other events
Showing 251–300 of 313 documents
Key facts
CIK
1711754
CUSIP
45782T105
13F (30d)
70 filings
58 filers
Visit website
Investor relations